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Abstract
Background: The international evidence about outcomes of End Stage Kidney Disease (ESKD) for ethnic minorities
was reviewed to identify gaps and make recommendations for researchers and policy makers.
Methods: Nine databases were searched systematically with 112 studies from 14 different countries included and
analysed to produce a thematic map of the literature.
Results: Reviews (n = 26) highlighted different mortality rates and specific causes between ethnic groups and by
stage of kidney disease associated with individual, genetic, social and environmental factors. Primary studies
focussing on uptake of treatment modalities (n = 19) found ethnic differences in access. Research evaluating
intermediate outcomes and quality of care in different treatment phases (n = 35) e.g. dialysis adequacy, transplant
evaluation and immunosuppression showed ethnic minorities were disadvantaged. This is despite a survival
paradox for some ethnic minorities on dialysis seen in studies of longer term outcomes (n = 29) e.g. in survival time
post-transplant and mortality. There were few studies which focussed on end of life care (n = 3) and ethnicity.
Gaps identified were: limited evidence from all stages of the ESKD pathway, particularly end of life care; a lack of
system oriented studies with a reliance on national routine datasets which are limited in scope; a dearth of
qualitative studies; and a lack studies from many countries with limited cross country comparison and learning.
Conclusions: Differences between ethnic groups occur at various points and in a variety of outcomes throughout
the kidney care system. The combination of individual factors and system related variables affect ethnic groups
differently indicating a need for culturally intelligent policy informed by research to prevent disadvantage.
Keywords: Inequalities, Ethnic minorities, Kidney disease, Scoping, Review
Background
Inequalities in some aspects of End Stage Kidney Disease
(ESKD) in the United Kingdom (UK) had been well docu-
mented prior to this study. However, to ensure that future
research would be based on the most comprehensive evi-
dence this scoping review was commissioned by a national
kidney charity in 2017, the topic having been identified
through prioritisation process involving people affected by
kidney disease as well as clinicians and researchers. This
review was the first step in a systematic approach to learn
as much as possible from the evidence about inequalities
in outcomes for people living and dying with ESKD who
are from ethnic minority groups. This paper describes the
approach (protocol) used, presents a map of the literature
and highlights where there are gaps to be addressed
through future research and policy.
Investigating inequalities in kidney care and how they
impact upon ethnic minorities is not only necessary for
reducing inequalities in the UK but is also likely to bene-
fit the understanding of access to care for other groups
with ESKD globally as well. This review therefore took a
broad perspective and incorporated the international lit-
erature. The objectives of this international systematic
scoping review were to:
 identify the evidence base of inequalities in the
outcomes of end stage kidney disease for ethnic
minorities;
 map the international literature;
 identify gaps and make recommendations for
research and policy towards reducing and
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: gurch.randhawa@beds.ac.uk; Gurch.randhawa@beds.ac.uk
1Institute for Health Research, University of Bedfordshire, Luton, Bedfordshire,
UK
Full list of author information is available at the end of the article
Wilkinson et al. BMC Nephrology          (2019) 20:234 
https://doi.org/10.1186/s12882-019-1410-2
preventing inequalities in kidney care in the UK and
globally.
Methods
This systematic scoping review was conducted in line
with the 5 stage framework outlined by Arksey and
O’Malley [1]: protocol and search question development;
systematic searching and record management; sifting
and refining; charting and mapping. The research ques-
tion was initially determined via a Delphi study and then
refined via discussion within the project team to “Why
do ethnic minority patients with End Stage Kidney
Failure (ESKD) experience poorer outcomes than non-
ethnic minority patients?”.
A systematic scoping review is an early and essential
step towards answering the ‘why’ question but necessar-
ily falls short of doing so as it does not apply or build
theory for this. It provides a map of the literature, high-
lights the issues that other researchers have addressed
and shows where there are gaps. It follows a systematic
protocol as described in this Methods section and offers
up observations and recommendations for next steps
which are listed in the Conclusion.
The search strategy and literature searches were
formulated and refined by EW and AB to be compre-
hensive and include sources from health, sociology and
psychology which considered minority health and any
aspect of end stage kidney disease (dialysis, renal re-
placement therapy, transplant or conservative care and
end of life care) in comparison to non-ethnic minorities
and in relation to the following outcomes:
 Morbidity, mortality, kidney related, service related,
transplant related
 Measures of mental health (e.g. reduction in anxiety
or depression using validated tools)
 Measures of emotional well-being or quality of life:
(using validated tools).
The definition of ethnic minority was taken from Cul-
ley [2] and ethnicity defined as ‘a consciousness of
belonging to a particular group based on commonality
of family origin and culture of shared values and beliefs
which is socially constructed’.
A time frame of 1992 onwards was set to capture
evidence from the last 25 years. The searches were wide
and sensitive and encompassed a range of thesaurus and
free text terms to describe the different descriptors of
ethnic minorities and the capture the terms related to
end stage kidney failure or disease. Table 1 provides an
example of one search strategy for one database.
9 electronic databases were searched to identify
studies for inclusion in the review (see Table 2
below). There was insufficient resource within the
project to search journals and grey literature that
could have expanded the potential range of studies
to be included.
The searches were undertaken by EW and AB in Au-
gust 2017 and all records were uploaded on to the End-
note database. Using the inclusion and exclusion criteria
shown in Table 3, each record was screened independ-
ently on the basis of title by the researcher (EW). A 10%
sample of titles were screened by a different member of
the research team, any discrepancies resolved, and then
the studies were screened by abstract and full text by
EW and either included or excluded according to the
criteria.
Figure 1 illustrates the searching and sifting process
for this review. Data was extracted into a series of evi-
dence tables by EW and MW following project team dis-
cussions regarding the column headings and data to be
extracted. This included details on author, publication
year, author country, ethnic group(s) in focus, research
type, research objective, outcomes / indicators and brief
summary of findings.
The data was analysed thematically and a map of the
data produced to aid analysis, see Fig. 3.
Results
112 studies were included in this review. These focussed
on ESKD and included analysis of outcomes for ethnic
minorities in 14 different countries listed in Fig. 2 which
shows a breakdown of the included papers by author
country of origin and / or country focus. The majority of
included studies concerned the US (n = 72) followed by
the UK (n = 15), Australia (n = 9), Canada (n = 4) and the
Netherlands and New Zealand (n = 3) with the other
eight countries (Singapore, Brazil, Mexico, Romania,
Israel, France, Hungary and India) being the focus of
only one or two studies each.
Included studies related to five different areas or themes
which were identified as: an overview of the question topic
area in the form of a review (Theme 1); access to a modal-
ity of RRT care i.e. access to haemodialysis, peritoneal dia-
lysis, conservative care (Theme 2); care on dialysis and /
or being listed for a transplant and moving through the
transplant process with a focus on intermediate outcomes
(Theme 3); longer term outcomes and survival (Theme 4)
and end of life care (Theme 5).
Theme 1 reviews of the topic area
Twenty-six included studies were reviews, none of which
systematic, and they ranged in scope and detail subdivid-
ing into five subsets: those with a focus on CKD, hyper-
tensive kidney disease, a general focus, dialysis and
transplantation.
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Reviews with a focus on CKD [3–7]
As survival and risk change over time and according to
stage and treatment, these studies suggested that inter-
ventions should be stratified and tailored in a similar
way with prospective longitudinal and cohort research
needed which include ethnic minority groups. Further-
more, the multiplicity of factors which put different eth-
nic minorities at increased risk of CKD and ESKD
(hypertension, Type 2 Diabetes Mellitus (T2DM), albu-
minuria) call for a complex analysis of system-related as
well as physiological factors through more cross popula-
tion multi-levels studies. The urgency of prevention in
countries where there are geographical and economic
constraints on access to dialysis but increasing incidence
in ESKD amongst particular indigenous groups,
highlighted the ethical and moral necessities of interven-
tion from a global perspective.
Review with a focus on hypertensive kidney disease [8]
This paper illustrated the different patterns in ESKD
among different ethnic groups within diverse popula-
tions which vary from country to country and how eth-
nicity relates to hypertensive kidney disease as the
predominant cause of ESKD for African Americans. The
range of mediators which can impact on hypertensive
ESKD e.g.: socio-demographics; access to healthcare;
Table 1 Example of one search strategy (Medline database)
1. exp. Kidney Failure, Chronic/
2. exp. Renal Replacement Therapy/
3. kidney/
4. exp. kidney diseases/
5. exp. renal insufficiency/
6. exp. renal dialysis/
7. Glomerular Filtration Rate/
8. transplantation.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10. Treatment Outcome/ or “Outcome Assessment (Health Care)”/ or
outcome assessment.mp. or “Outcome and Process Assessment (Health
Care)”/
11. outcome measure*.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
12. exp. Health Status/
13. exp. “Quality of Life”/
14. health impact assessment/
15. well-being.mp.
16. exp. Mental Disorders/
17. exp. Depression/
18. Anxiety/
19. Stress, Psychological/
20. exp. Dementia/
21. exp. Cardiovascular Diseases/
22. end of life care.mp. or Terminal Care/
23. palliative care.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
24. conservative care.mp. [mp = title, abstract, original title, name of
substance word, subject heading word, keyword heading word,
protocol supplementary concept word, rare disease supplementary
concept word, unique identifier, synonyms]
25. mortality.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
26. morbidity.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
27. survival.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
28. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21
or 22 or 23 or 24 or 25 or 26 or 27
29. exp. Ethnic Groups/
30. exp. Continental Population Groups/
31. exp. Minority Health/
32. bme.mp.
33. bame.mp.
34. racial.mp.
35. cald.mp. [mp = title, abstract, original title, name of substance word,
subject heading word, keyword heading word, protocol supplementary
concept word, rare disease supplementary concept word, unique
identifier, synonyms]
36. south asian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
37. indo asian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
Table 1 Example of one search strategy (Medline database)
(Continued)
38. indian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
39. caucasian.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
40. exp. African Americans/
41. exp. Hispanic/
42. exp. White/
43. exp. Black/
44. indigenous.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
45. inequality.mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept
word, unique identifier, synonyms]
46. exp. Health Status Disparities/ or exp. Prejudice/ or exp. Ethnic
Groups/ or intersectionality.mp. or exp. “Emigration and Immigration”/
or exp. Social Class/
47. 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40
or 41 or 42 or 43 or 44 or 45 or 46
48. exp. research design/
49. exp. empirical research/
50. exp. qualitative research/
51. 48 or 49 or 50
52. 9 and 28 and 47 and 51
53. limit 52 to yr. = “1992 -Current”
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blood pressure management; and differences in
outcomes on renal replacement therapy (RRT) were
described. The earlier onset and more severe disease
could be partly explained by worse access to healthcare
associated with lower socioeconomic status.
Reviews with a general focus [9–11]
These studies provide some general observations on
inequalities in relation to a variety of different ethnic
groups and African and Native Americans. There is
more rapid progression from CKD to ESKD in ethnic
minorities; minority groups have worse access to care
and late referral to specialist renal care. Although
transplantation is the ‘best’ treatment for many
people, wait time to transplantation is longer for eth-
nic minorities due to delays in completing the trans-
plant evaluation process and because of lack of
suitable matched organs. These three reviews draw at-
tention to the need for culturally competent preven-
tion at the same time as continuing with research to
investigate why there are different outcomes seen in
ethnic minority groups. The influence of socio-
economic factors such as education, social status and
associated attitudes towards treatment options for
ESKD, and quality of life on RRT compared to major-
ity population groups, are aspects which require bet-
ter understanding.
Reviews with a focus on dialysis [12–16]
Five reviews focussed on ESKD from the perspective
of dialysis services in the UK, Europe, the US and
other parts of the world e.g. Israel. The overarching
premise was that the incidence of ESKD and associ-
ated need for dialysis is steadily increasing with differ-
ences between ethnic groups and associated with
changing age structure of populations. These reviews
with a focus on different aspects of dialysis care came
with the caveat that long term survival of ESKD is
very low and survival advantages on dialysis are mar-
ginal compared to transplantation with a living donor
graft which can extend life considerably but still not
back to normal lifespan. Although a survival advan-
tage has been seen in some ethnic groups on dialysis
a need for a better understanding of the underlying
mechanisms behind the differences and taking action
on barriers to access both in the pathway to ESKD
but also in access to care on dialysis including trans-
plantation was highlighted.
Table 3 Inclusion and Exclusion Criteria
Inclusion Exclusion
● Studies (including systematic reviews and all study designs) that mention
ethnic minority health in line with the above definition and in relation to end
stage kidney disease and related descriptions (end stage renal failure, dialysis,
end of life kidney care).
● Evidence of a measurable outcome on health or wellbeing (e.g. physical or
mental health or physiological or quality of life or wellbeing)
● Studies which concern any of the related end stage kidney disease descriptors:
○ Patients on any kind of dialysis
○ Patients on Renal replacement therapy
○ Transplant patients
○ End stage renal failure
● Adults over 18
● Studies in English, post 1992
● Any country
● A comparison with non-ethnic minority group (s)
● Studies outside the agreed definition of ethnic minority
● Studies with no measurable outcomes that relate to health
● Studies which do not concern any of the related end stage
kidney failure descriptors:
○ Patients on any kind of dialysis
○ Transplant patients
○ End stage renal failure
● Children less than 18
● Studies in languages other than English, prior to 1992
● Studies that do not have a comparison with non-ethnic
minority group (s)
● Studies that are commentaries, editorials (which do not
present data), thought pieces or conference abstracts
Table 2 Databases searched and number of references retrieved
Database name Focus Number of references retrieved
Medline Biomedical 185
Cinahl Nursing and allied health 534
Psychinfo Psychology/Mental Health 78
Web of Science/Web of Knowledge Science/Social Sciences 224
Scopus General 577
Social Care Online Social Care 53
ASSIA Social Science 370
Global Health Health 97
Cochrane Database of Promoting Health Effectiveness Reviews Systematic Reviews 17
Total 9 databases 2135
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Fig. 2 Breakdown of included articles by country of author origin and / or focus
Fig. 1 Searching and sifting process
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Reviews with a focus on transplantation [17–28]
Twelve reviews concerned inequalities in the trans-
plantation process or transplantation outcomes. The
overarching premise being that ethnic minorities, al-
though disproportionately represented in patient
populations with ESKD, receive fewer transplants
and wait longer to receive a transplant. These re-
views gave perspectives that varied according to the
level of focus: global; country; population; individual
as well as stage in the transplant process (pre-emp-
tive transplantation, referral to waiting list, organ al-
location, graft survival and immunosuppression) and
donation. Overarching conclusions were that better
understanding and communication would lead to in-
creased awareness of how the social and individual
risk factors interact through the system which is ne-
cessary for improving access and reducing
inequalities.
Theme 2 disparities in access & treatment modalities
Nineteen studies reported access to kidney care treat-
ment modalities - dialysis, transplant and conservative
care, post diagnosis of ESKD.
Sixteen out of the 19 were cohort designs, 1 observa-
tional – cross sectional, 1 mixed method and ethno-
graphic, 1 other (review of registry report data). The
studies spanned 6 countries.
Indicators related to access to RRT modalities were:
incidence or prevalence on the modality; rate of accept-
ance; planned and unplanned initiation; time to modal-
ity; waiting list probability; time from acceptance onto
waiting list to transplantation (and rate); time from start
of RRT to transplantation (and rate); transplantation
rate.
Access to dialysis – peritoneal dialysis and hemodialysis
[29–37]
Studies described differences in uptake of dialysis mo-
dality by different ethnic minority groups compared
to majority populations. These were not consistent
between different countries and different minority
populations highlighting that despite commonalities
ethnic minorities are diverse groups whose experi-
ences vary from country to country and on an indi-
vidual level.
The sociocultural context of renal replacement therapy
featured as an important consideration with a focus on
possible explanatory factors for the larger prevalent eth-
nic minority population on dialysis compared to the
general population. A third of the countries represented
in this review had a national kidney data service which
contributed to the research picture by providing quanti-
tative analysis of some elements.
Access to transplantation [38–47]
Studies showed that ethnic minorities with ESKD are
disproportionately represented in the transplantation
modality and identified a range of reasons that relate to
the different countries’ transplant systems. These
included the rates of being listed for transplant; move-
ment from list to transplantation; variations across
transplant centres as well in pre-dialysis care and cadav-
eric and life donation rates, which all showed disparities
when ethnic minorities were compared with majority
populations. The requirement for future research and
service development to take stratified and systemic ap-
proaches towards improving access to transplantation to
redress these inequalities was raised - as despite being
highly technical, dialysis and transplantation are part of
a complex process which is influenced by human and
sociological factors.
Theme 3 disparities in quality of care and intermediate
outcomes
Thirty-five studies investigated ethnic differences in
intermediate outcomes of treatment for ESKD.
Sixteen out of the 35 were cohort designs, 12 other
observational (cross sectional, survey, discrete choice ex-
periment); 3 other (programme review, record review,
simulation), 3 qualitative and 1 randomised controlled
trial (RCT). The studies spanned 6 countries.
Intermediate outcomes related to kidney function
were: estimated glomerular filtration rate (eGFR); pro-
teinuria / serum albumin; indicators of quality of care
e.g. dialysis dose / dialysis adequacy expressed as Kt/V,
urea reduction ratio (URR), anaemia and mineral man-
agement, infections, hospitalisation, communication &
information; indicators of health and wellbeing or behav-
iour i.e. nutritional status, quality of life (QOL), coping
style; indicators for movement through clinical pathways
i.e. through the transplant evaluation and allocation
process; transplant indicators e.g. antibody matching,
immunosuppression; and indicators of organisational or
system function e.g. issues of insurance, allocation prior-
ities, centre level variations, system level intervention.
Ethnic minorities are younger at referral to specialist
kidney care and as they often face a longer wait for a
transplant so that time spent on dialysis or moving
through the transplant process is both an opportunity
and a risk for outcomes later in the pathway. The choice
of dialysis modality and type of vascular access can be
associated with ESKD outcomes and researchers investi-
gated these for disparities amongst ethnic groups.
Quality of care - dialysis [48–63]
Studies reported on indicators of dialysis care such as
hemodialytic dose as well as clinical outcomes such as
time to first infection episode and found there these
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varied by different ethnic groups and required further
explanation. Other indicators of maintaining health
whilst on dialysis and associated outcomes such as qual-
ity of life similarly suggested a stratified approach to
identifying related inequalities was necessary as there are
age, gender and ethnicity associations to be understood.
Links back to wider system variables again were made.
Quality of care– transition to transplant [64–75]
Ethnic disparities in the transition from diagnosis of
ESKD or dialysis to transplant were investigated in 10 of
the included studies. The low transplant rates for ethnic
minorities which are seen overall in many countries can
be linked to disparities further back in the pathway well
as availability of suitable donor organs. Barriers respon-
sible for differences in completion of stages and move-
ment through the transplant process were associated
with minority ethnicity and linked to levels of informa-
tion given, knowledge and communication between pa-
tient and physician but also within wider networks.
Quality of care – the system [76–82]
Disparities in the transplant process were associated
with ethnicity for some groups and related to interaction
with kidney allocation and transplantation systems and
influenced by a wide range of factors such as geography,
clinician–patient communication, insurance and vari-
ation across centres in the same system. These studies
highlighted the complexity of transplantation systems.
Theme 4 disparities in longer term outcomes
Twenty-nine studies focussed on patient survival out-
comes for dialysis and transplantation.
Twenty-five out of the 29 were cohort designs and 4
were other observational studies. Collectively they inves-
tigated differences in outcomes across 12 broad ethnic
groups, 3 analysing by ethnic subgroups. The studies
spanned 8 countries.
Longer term outcomes relating to dialysis and trans-
plantation were: survival time on dialysis; time post-
transplant; hospitalisation, infection; allograft rejection;
quality of life (QOL); and mortality.
The outcomes for dialysis and transplantation varied
across different ethnicities, subgroups and stratification
by other variables: age, comorbidities (type 1 diabetes
mellitus (T1DM), type 2 diabetes mellitus (T2DM),
Lupus Nephritis) and location.
Overarching outcomes of ESKD [83–87]
Studies that reported the overarching outcomes of ESKD
identified inequalities faced by particular populations
and subgroups drawing attention to the disproportionate
burden of dialysis and mortality attributed to rates and
risk of diabetes and kidney complications. Other studies
highlighted how ethnic inequalities in outcomes can be
linked to area differences within countries and across
regions.
Dialysis outcomes [88–101]
Some ethnic minorities have been found to have longer
survival on dialysis than the majority population and this
apparent survival paradox is against the background of
increased risk, faster progression to ESKD and poorer
survival in the general population overall. The dialysis
survival advantage was not seen to be consistent across
the groups studied with different ethnicities and comor-
bidities; cultural and genetic differences as well as vari-
ation in access and delivery of care accounting for this.
Transplantation outcomes [102–111]
The reduced likelihood of having a transplant is a dis-
parity many ethnic minority patients face and studies in-
vestigated risks as well as survival outcomes. Ethnic
group and comorbidities were found to be associated
with this with greater disparities seen when live and de-
ceased donation were compared. To understand the im-
pact of ethnicity on transplant survival outcomes
research investigated other risks underpinning delayed
graft function, acute rejection episodes, expanded-
criteria donor, impaired graft function which for some
ethnicities was an independent risk. Differential rates of
risks and survival between ethnic groups were found in
some studies.
Theme 5 disparities in end of life care [112–114]
Three studies that focussed on disparities in end of life
care for people with ESKD were included in this review.
These studies all came from one country, the US. Two
had RCT designs and 1 was a cohort study.
Ethnic minorities were less likely to withdraw from
dialysis before death than the majority population with
differences explained by sociocultural rather than med-
ical factors. Research in this area included two studies
which attempted to understand and improve end of life
care for all kidney patients through culturally sensitive
intervention.
Discussion
ESKD is a multifaceted condition with many clinical and
sociological elements and there are multiple stages and
timings to consider in achieving the best outcome for
individuals living with the condition. Within the re-
search literature individuals are generally aggregated into
groups to look for evidence of inequalities and this
international scoping review has identified that there are
disparities between ethnic and non-ethnic minority
populations in all aspects of ESKD progression and
management.
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The search strategy for this review was formulated and
conducted by an experienced health researcher (EW) and
an expert in literature searching and systematic reviewing
(AB). It was designed to be as wide as possible within the
resource and time constraints for the work. Tests for pub-
lication bias were not conducted nor were reference lists
mined or grey literature searched, and these are limita-
tions. However, the research question and search strategy
were kept intentionally broad, reviews were included, and
the search resulted in studies that used a range of different
outcome indicators which related to the different clinical
and social elements and stages of care for ESKD. The
variety of studies and their juxtaposition within the ESKD
field enabled a useful overview of the evidence base,
notwithstanding any publication bias.
Figure 3 is a visual representation of the main themes
in relation to each other and served to highlight some of
the gaps. The different themes corresponded to specific
elements of the kidney care system – access to treatment
modalities, dialysis, transplantation and end of life care
– and this review is the first, as far as we are aware, to
map the evidence of inequalities in the ESKD field as a
whole. This review therefore is a comprehensive starting
point for researchers and policy makers to consider
where and in what form evidence exists on inequalities
in ESKD for ethnic minorities.
Although this review mapped the literature across a
schematic ESKD pathway, it highlighted an absence of
longitudinal cohort studies (retrospective or prospective)
which followed CKD patients as they progress through
that pathway. There was also a dearth of studies in two
particular areas of ESKD: system-related outcomes and
end of life care. The lack of longitudinal and system-
related studies may be due to the difficulties of conduct-
ing complex systems-related research whereas the lack
of end of life studies could reflect a lack of recognition
of end of life care as distinct element of kidney care, as
well as difficulties in defining end of life and barriers to
conducting research in that context.
The literature was also predominantly quantitative and
so was limited in helping understand the basis of the dif-
ferences in outcomes between ethnic groups. Although
national registries were a valuable source of data, espe-
cially regarding records and analyses of outcomes by
ethnic group [13], the national routine datasets do not
include indicators for all elements of care, nor analysis
at an individual level. Cultural aspects of ethnicity such
as attitudes towards death and dying come into play at
end of life and there are cultural differences between dif-
ferent parts of healthcare systems so that more qualita-
tive research would help understanding of the individual,
cultural and social factors which influence the disparities
in outcomes in these and other areas of ESKD. Further-
more, more qualitative and mixed method studies would
help to build theories about why inequalities exist and
how they can be addressed going forward.
Fig. 3 A map of the international literature on comparative studies of minority ethnicity and ESKD
Wilkinson et al. BMC Nephrology          (2019) 20:234 Page 8 of 12
The majority of the evidence for this review has
come from a small number of countries and regions
notably the US, UK and Australasia. Reasons for the
lack of research in other countries, particularly in
lower income settings, may reflect how kidney care is
funded and delivered in individual countries; the ab-
sence of national data sets concerning ESKD; or the
lack of ethnicity data. This review highlights the com-
plexities of the kidney and transplant care systems
which people with ESKD engage with. Systems in dif-
ferent countries may share some common features
but they may also be country specific so that more
research and analyses of inequalities in ESKD globally,
with cross country comparisons, and a systems ap-
proach, would help to share learning and build on
this evidence.
Individual countries like the UK, where there is
the National Health Service and a national kidney
data registry, can not afford to rest on their laurels
because as Feehally [9], Lightstone [12] and Rand-
hawa [27] have been suggesting over the past 20
years, the UK’s changing demography towards
greater ethnic diversity together with a donation
shortage, means that without concerted evidence-
based intervention ethnic minorities will continue to
experience inequalities in outcomes for ESKD. Fur-
thermore, as ethnic minorities are highly heteroge-
neous groups, culturally intelligent approaches are
needed to understand the barriers and enablers of
access within individual country systems and to learn
from international comparisons.
Conclusions – gaps in the evidence
Differences between ethnic groups occur at various
points and in a variety of outcomes throughout the
ESKD care system. The combination of individual fac-
tors and system related variables affect ethnic groups
differently indicating a need for culturally intelligent pol-
icy informed by research to prevent disadvantage.
This thematic analysis contributes to the international
research evidence by mapping the different elements of
ESKD research where inequalities for ethnic minorities
have been observed. A number of gaps in the inter-
national literature have been highlighted which if ad-
dressed would strengthen our understanding of why
inequalities exist for people from ethnic minority groups
who are living and dying with ESKD.
Gap 1
There is a lack of evidence at all stages in the ESKD
pathway and a lack of longitudinal cohort studies (retro-
spective or prospective) which follow CKD patients as
they progress through the pathway.
Gap 2
The lack of system oriented research into ESKD and a
reliance on primary studies using national routine data
limits our understanding of how the different elements
in the system work together.
Gap 3
There is a lack of qualitative studies contributing to the
evidence base and the literature is predominantly quan-
titative. This limits a full understanding of the factors
that influence disparities in ESKD outcomes.
Gap 4
There is a lack of evidence from many countries apart
from the US, especially low-resource settings, and this
limits the possible learning across and between
countries.
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